Karuna Therapeutics Inc. (KRTX) Prices 2.08M Share Common Offering at $120/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St set to snap three-day streak of losses despite Middle East clashes
- Oil rises 1%, as US-Iran strikes risk limiting already impaired supplies
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Google escapes ad tech breakup in third Big Tech antitrust loss for US
Karuna Therapeutics Inc. (KRTX) PT Raised to $165 at RBC Capital, Sees Underappreciated De-Risking
March 1, 2021 6:50 AM ESTRBC Capital analyst Brian Abrahams raised the price target on Karuna Therapeutics Inc. (NASDAQ: KRTX) to $165.00 (from $160.00) while maintaining a Outperform rating.
The analyst comments "Late last week, KRTX reported preliminary qualitative data from its ph.Ib study of lead drug KarXT in... More
Karuna Therapeutics Inc. (KRTX) Announces $200M Proposed Public Offering of Common Stock
March 1, 2021 6:19 AM ESTKaruna Therapeutics, Inc. (NASDAQ: KRTX) (Karuna), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that it has commenced an underwritten public offering of $200.0 million of its common stock. Karuna also intends to grant the underwriters a 30-day... More
Karuna Therapeutics Inc. (KRTX) PT Raised to $148 at Oppenheimer
March 1, 2021 5:09 AM ESTOppenheimer analyst Jay Olson raised the price target on Karuna Therapeutics Inc. (NASDAQ: KRTX) to $148.00 (from $135.00) while maintaining a Outperform rating.... More
Karuna Therapeutics Inc. (KRTX) PT Raised to $150 at Mizuho Securities
February 26, 2021 6:44 AM ESTMizuho Securities analyst Vamil Divan raised the price target on Karuna Therapeutics Inc. (NASDAQ: KRTX) to $150.00 (from $116.00) while maintaining a Buy rating.... More
Karuna Therapeutics Inc. (KRTX) PT Raised to $175 at Citi
February 26, 2021 5:57 AM ESTCiti analyst Mohit Bansal raised the price target on Karuna Therapeutics Inc. (NASDAQ: KRTX) to $175.00 (from $115.00) while maintaining a Buy rating.... More
